Skip to main content

Leukomed® Control

Leukomed® Control is a fully transparent post-op dressing allowing for early detection of wound infection.

Essity

Hydrofera, LLC and BSN Medical Inc. are Essity-owned companies. Essity is a leading global hygiene and health company dedicated to improving well-being through products and solutions. They provide high quality wound and incontinence care, orthopedic, and compression products. Essity sells in approximately 150 countries under leading global brands Cutimed®, Hydrofera Blue®, Leukoplast®, JOBST®, Delta-Cast®, and TENA®.
Toll free:(800) 552-1157 Website: www.essityusa.com
Benefits

• Creates optimal moisture levels and adapts to skin's elasticity
• Innovative hydropolymer technology that manages exudate
• Fully transparent to allow early detection of wound infection

Indications

Leukomed® Control is indicated for dry and low exuding acute wounds such as surgical wounds, superficial partial-thickness burns, skin donor sites, lacerations and abrasions.

Contraindications

Leukomed® Control is not indicated for surgical implantation, to control heavy bleeding, for third-degree burns or for placement inside deep cavities or sinuses.
Not suitable for use under a compression bandage or for radiation therapy.

Warnings and Precautions

Leukomed® Control is for single use only. Do not use if the package is already open or damaged, as the sterility of the dressing is guaranteed only when the package is unopened and undamaged prior to use.
Leukomed® Control may be used on infected wounds only after consulting a health care professional.
Do not use on patients with a known sensitivity to glycerine or hydrogels. In case of intolerance, remove the dressing and gently cleanse the wound with water or sterile saline solution.
The dressing may be moistened with sterile saline solution for easier removal.
Should gel fragments remain in the wound bed after removing the dressing, these may be removed by irrigation with sterile saline solution or water.
During the body’s normal healing process, non-viable tissue is removed from the wound, which could initially make the wound appear larger. If the wound continues to grow larger after the first few dressing changes, consult a health care professional.
Because Leukomed® Control creates an environment that favors the growth of new blood vessels, the delicate newly formed blood vessels may occasionally produce blood stained wound fluid. If excessive bleeding occurs, the dressing may be used together with an alginate wound dressing.
Monitor the wound carefully. Leukomed® Control can remain in situ for up to seven days, depending on the wound condition. The total duration of contact (i.e., where the treatment involves consecutive application of individual dressings) is 30 days.
Do not use the product after the expiry date.
No data are available that support the use of topical medicinal preparations in conjunction with Leukomed® Control.
For external use only.

Storage Requirements

Protect from moisture and store dry at temperatures below 25°C (77°F).

How Supplied/Sizing
2"x2(3/4)", 2(3/4)"x4", 3(1/8)"x6", 4"x9(1/2)", 4"x13(3/4)".
HCPCS Code
Product features
check_circle Adhesive border
cancel Antimicrobial format available
cancel Conforms readily to wound
cancel Cuttable
cancel Freeze-dried
cancel Gels on contact w/ exudate
cancel Impermeable to outside contaminants
check_circle Moldable
check_circle One-piece removal
cancel Paste
check_circle Self-adhering
check_circle Variety of sizes
Other features
check_circle Educational Material Available
check_circle Free Samples/Trials Available
cancel Published Clinical Article Available

No posters match your selected filters. Remove some filtres, or reset them and start again.

Have a product to submit?

Be included in the most comprehensive wound care products directory
and online database.
Learn More